Protagenic Therapeutics, Inc. (PTIX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
149 Fifth Avenue
New York City, NY 10010
United States of America (the)
Phone
212 994 8200
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
April 27, 2021
| Name | Title | Pay | Year Born |
| Alexander Kenneth Arrow | Chief Financial Officer | 0 | 1971 |
| Robert Benjamin Stein | Chief Medical Officer | 0 | 1951 |
| William Nichols Jr. | President | 0 | 1975 |
| Garo H. Armen | Executive Chairman | 0 | 1953 |
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated peptide. This compound functions by emulating an innate brain signaling peptide, known for its ability to temper exaggerated stress reactions. The company's headquarters are located in New York, New York.